McMaster University engineers have devised a way to make testing for new drugs more efficient and affordable, and reduce the time for helpful medications to reach the public
Chemical Engineering Associate Professor Todd Hoare and Rabia Mateen, a PhD candidate in Biomedical Engineering, have created a printed paper-based device that can speed up and improve the accuracy of the drug screening process. Their work, which could also be used to diagnose diseases, identify environmental contaminants and pinpoint biological warfare agents, was published in Nature Communications in February.
Currently, drug testing is done in multiple stages, with the first stage involving testing thousands of drug candidates in rapid succession to see how well they bind, block or degrade a molecule of interest to the target disease. Subsequent stages involve more extensive testing of drugs that show promise in this first step.
However, the way this initial first screen is now done results in many inaccurate results, with as many as 95% of drug candidates having no chance of becoming a useful drug. In most cases, these inaccuracies arise from the candidate drugs sticking together during the screen to create particles that physically, instead of chemically, block the activity of the molecule targeted by the drug. Such inaccuracies are only now discovered in the slower and more expensive second stage of screening, resulting in significant time and money wasted during the drug discovery process.
Hoare and Mateen have come up with a way to improve the first stage of testing by using a new printable hydrogel, a network of polymers used in everything from contact lenses to disposable diapers. The thin layers of printed hydrogels can form a cage around the target molecule so drug particles formed can’t access the target molecule and trigger the inaccurate result. Instead, only drugs that chemically bind to the target molecule (the ones that could become practical drugs) are allowed into the hydrogel to give a positive result. The printed device developed is inexpensive and can be used directly in drug screening, improving accuracy without requiring a significant change in how drug screening is now done. As an added benefit, the same sensitivity can be achieved using much less sample volume, further reducing the cost of the screen.
“We had already developed the printing method, but were not sure what to do with the materials,” Mateen said. “Reading about this significant issue in the area of drug screening made me realize that these materials could directly address this problem in a simple and effective way.”
The researchers expect this to make testing more affordable and to speed up the discovery of new drugs. In addition, to help address the surge of antibiotic resistance, the technology can also help to more quickly identify “helper drugs” that can make even drug-resistant bacteria susceptible to our current antibiotics.
“As the next step, we are looking for industry partners to prove the effectiveness of our technology on a full-scale screen of thousands of molecules that can help to extend the lifetime of our current antibiotics,” Hoare said. “We are optimistic this approach can help to bring new effective drugs to patients faster than is currently possible”.
The Latest on: Drug discovery
The power of precision medicine in cancer drug discovery and treatment
on March 14, 2018 at 1:19 am
Dr Olivia Rossanese is finding new ways to target cancer with drugs and previously, at GlaxoSmithKline, was in the team that discovered the targeted cancer treatment, and BRAF inhibitor, dabrafenib. Our Communications Administrator, Tilly Haynes, heard ... […]
Traffic stop leads to drug discovery in Hattiesburg
on March 13, 2018 at 3:45 pm
Two Mississippi men were arrested in Hattiesburg after a traffic stop led to the discovery of illegal drugs Monday night. According to the Hattiesburg Police Department, officers pulled over a vehicle for having one headlight on 7th Street around 10 p.m. A ... […]
South America Drug Discovery Market – Size, Outlook, Trends and Forecasts (2018 – 2024)
on March 12, 2018 at 12:11 pm
The report provides an extensive analysis of sales, revenue, growth rate, and key market players for the historic period and the forecast period, Moreover, marketing channels, major distributors, and supply channels are discussed in the study The report ... […]
Global Drug Discovery Informatics Market Expected to Reach a Value of US$ 7.8 Bn by 2025 - Outsourced Informatics to Fuel Market Growth
on March 9, 2018 at 4:35 am
The global drug discovery informatics market was valued approximately US$ 2.0 Bn in 2016 and is anticipated to register CAGR of over 17.0% from 2017 to 2025 to reach value of approximately US$ 7.8 Bn by 2025, according to a new market report published by ... […]
Mother-daughter duo joins Y Combinator to accelerate drug discovery platform Macromoltek
on March 8, 2018 at 2:36 am
While some Silicon Valley tech titans infuse themselves with rejuvenating blood in the hopes of living longer, others work on accelerating drug discovery to cure actual diseases. Dr. Monica Berrondo and her mother, Susana Kaufmann, founded Macromoltek in ... […]
Atomwise Raises $45M for Artificial Intelligence Platform for Drug Discovery
on March 7, 2018 at 5:32 am
Atomwise, a San Francisco, CA-based company that develops artificial intelligence systems for drug discovery has raised $45 million in Series A funding led by Monsanto Growth Ventures, B Capital Group and Data Collective. Prior investors Y Combinator ... […]
GSK's Bid To Accelerate Drug Discovery Using AI
on March 7, 2018 at 3:23 am
GSK’s goal is to transform drug discovery from a slow, sequential, high-failure process into a rapid, integrated, and patient-focused model with the help of tools like artificial intelligence and data. We spoke to Mark Ramsey, chief data officer for R&D ... […]
How Stale Is Innovation in Drug Discovery? Think: 5-Year-Old Yogurt.
on March 6, 2018 at 11:43 am
IDEA Pharma, a leading drug industry consultancy, has released its 2018 “Freshness Index”—one of my favorite parts of the firm’s much-awaited annual Pharmaceutical Innovation Index (which is slated to arrive at the end of this month). If you want a ... […]
Global drug discovery outsourcing market to grow at a CAGR of 12.13% according to market forecasts
on March 6, 2018 at 3:49 am
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Drug Discovery Outsourcing Market. Drug Discovery Outsourcing ... […]
via Google News and Bing News